Professor Des Richardson Prof richardson holds the alan mackay sim distinguished chair of cancer cell biology at griffith university and is a national health and medical research council (nhmrc) of australia senior principal research fellow. he is also the director of the centre for cancer cell biology and drug discovery. he has published >454 articles, reviews. Prof. des r. richardson brief biography. professor des richardson holds the position of alan mackay sim distinguished chair of cancer cell biology at griffith university (inaugural chair – first named chair at griffith university in its 50 year history), nathan, brisbane, and is a national health and medical research council (nhmrc) of australia senior principal research fellow.
Meet The Researcher Professor Des Richardson 30 Seconds Youtube Richardson reasearch centrei s a hub for great scientists at all levels ranging from highly experienced to young and upcoming researchers. centre for cancer cell biology and drug discovery (cbdd) is a griffith university affiliated medical research centre focusing on multi disciplinary cancer and parkinson's disease research. this centre is led. Read about des' research here: nbcf.org.au project new anti cancer drugs for treatment resistant and advanced estrogen receptor positive er breast ca. Des r richardson background n myc downstream regulated gene 1 (ndrg1) is an established stress response protein. this study investigated the effects of ndrg1 on autophagic degradation and how this. The open access, advanced microscopy and imaging facility. cbdd’s discoveries under prof. richardson are summarized below and are divided into 3 sections: 1. development of “frontier” anti cancer drugs that overcome the triad of death: entrance into multi centre, clinical trials. richardson’s pioneering, interdisciplinary work on the.
Overcoming Treatment Resistant Cancers Raine Medical Research Foundation Des r richardson background n myc downstream regulated gene 1 (ndrg1) is an established stress response protein. this study investigated the effects of ndrg1 on autophagic degradation and how this. The open access, advanced microscopy and imaging facility. cbdd’s discoveries under prof. richardson are summarized below and are divided into 3 sections: 1. development of “frontier” anti cancer drugs that overcome the triad of death: entrance into multi centre, clinical trials. richardson’s pioneering, interdisciplinary work on the. Des r richardson for many years it has been known that neoplastic cells express high levels of the transferrin receptor 1 (tfr1) and internalize iron (fe) from transferrin (tf) at a tremendous rate. 2021. the evolution of iron chelators for the treatment of iron overload disease and cancer. ds kalinowski, dr richardson. pharmacological reviews 57 (4), 547 583. , 2005. 904. 2005. the molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. dr richardson, p ponka.
Current Projects Supervised Under Prof Des Richardson вђ Centre For Des r richardson for many years it has been known that neoplastic cells express high levels of the transferrin receptor 1 (tfr1) and internalize iron (fe) from transferrin (tf) at a tremendous rate. 2021. the evolution of iron chelators for the treatment of iron overload disease and cancer. ds kalinowski, dr richardson. pharmacological reviews 57 (4), 547 583. , 2005. 904. 2005. the molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. dr richardson, p ponka.
Comments are closed.